MRI in Leber's hereditary optic neuropathy:The relationship to multiple sclerosis

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 86, Issue 5, 2015, Pages 537-542

  Matthews, Lucy ^a,b   Enzinger, Christian ^c   Fazekas, Franz ^c   Rovira, Alex ^d   Ciccarelli, Olga ^e   Dotti, Maria Teresa ^f   Filippi, Massimo ^g   Frederiksen, Jette L ^h   Giorgio, Antonio ^f   Küker, Wilhelm ^a,b   Lukas, Carsten ⁱ   Rocca, Maria A ^g   De Stefano, Nicola ^f   Toosy, Ahmed ^e   Yousry, Tarek ^e   Palace, Jacqueline ^a,b  

^a OXFORD UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c MEDICAL UNIVERSITY OF GRAZ   (Austria)

^d HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^e UNIVERSITY COLLEGE LONDON   (United Kingdom)

^f UNIVERSITY OF SIENA   (Italy)

^g VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^h UNIVERSITY OF COPENHAGEN   (Denmark)

ⁱ ST JOSEF HOSPITAL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; HUMAN; LEBER HEREDITARY OPTIC NEUROPATHY; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; OBSERVATIONAL STUDY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; SEX DIFFERENCE; WHITE MATTER LESION; YOUNG ADULT; COMPLICATION; NEUROIMAGING; PATHOLOGY; SINGLE BLIND PROCEDURE; WHITE MATTER;

ADULT; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; NEUROIMAGING; OPTIC ATROPHY, HEREDITARY, LEBER; SEX FACTORS; SINGLE-BLIND METHOD; WHITE MATTER; YOUNG ADULT;

EID: 84927589540     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp-2014-308186     Document Type: Article

References (20)

1. Palace J. Multiple sclerosis associated with Leber's hereditary optic neuropathy. J Neurol Sci 2009;286:24-7.
2. Vanopdenbosch L, Dubois B, D'Hooghe MB, et al. Mitochondrial mutations of Leber's hereditary optic neuropathy: a risk factor for multiple sclerosis. J Neurol 2000;247:535-43.
3. Riordan-Eva P, Sanders MD, Govan GG, et al. The clinical features of Leber's hereditary optic neuropathy defined by the presence of a pathogenic mitochondrial DNA mutation. Brain 1995;118(Pt 2):319-37.
4. Lees F, Macdonald AM, Turner JW. Leber 's disease with symptoms resembling disseminated sclerosis. J Neurol Neurosurg Psychiatry 1964;27:415-21.
5. Kellar-Wood H, Robertson N, Govan GG, et al. Leber's hereditary optic neuropathy mitochondrial DNA mutations in multiple sclerosis. Ann Neurol 1994;36:109-12.
6. Man PY, Griffiths PG, Brown DT, et al. The epidemiology of Leber hereditary optic neuropathy in the North East of England. Am J Hum Genet 2003; 72:333-9.
7. Polman CH, Reingold SC, Banwell B, et al. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 2011;69:292-302.
8. Kuker W, Weir A, Quaghebeur G, et al. White matter changes in Leber's hereditary optic neuropathy: MRI findings. Eur J Neurol 2007;14:591-3.
9. Inglese M, Rovaris M, Bianchi S, et al. Magnetic resonance imaging, magnetisation transfer imaging, and diffusion weighted imaging correlates of optic nerve, brain, and cervical cord damage in Leber's hereditary optic neuropathy. J Neurol Neurosurg Psychiatry 2001;70:444-9.
10. Swanton JK, Fernando K, Dalton CM, et al. Modification of MRI criteria for multiple sclerosis in patients with clinically isolated syndromes. J Neurol Neurosurg Psychiatry 2006;77:830-3.
11. Kovacs GG, Hoftberger R, Majtenyi K, et al. Neuropathology of white matter disease in Leber's hereditary optic neuropathy. Brain 2005;128(Pt 1):35-41.
12. Mahad D, Ziabreva I, Lassmann H, et al. Mitochondrial defects in acute multiple sclerosis lesions. Brain 2008;131(Pt 7):1722-35.
13. Lu F, Selak M, O'Connor J, et al. Oxidative damage to mitochondrial DNA and activity of mitochondrial enzymes in chronic active lesions of multiple sclerosis. J Neurol Sci 2000;177:95-103.
14. Dutta R, McDonough J, Yin X, et al. Mitochondrial dysfunction as a cause of axonal degeneration in multiple sclerosis patients. Ann Neurol 2006;59:478-89.
15. Mahad D, Lassmann H, Turnbull D. Review: mitochondria and disease progression in multiple sclerosis. Neuropathol Appl Neurobiol 2008;34:577-89.
16. Campbell GR, Ziabreva I, Reeve AK, et al. Mitochondrial DNA deletions and neurodegeneration in multiple sclerosis. Ann Neurol 2011;69:481-92.
17. Ban M, Elson J, Walton A, et al. Investigation of the role of mitochondrial DNA in multiple sclerosis susceptibility. PLoS ONE 2008;3:e2891.
18. Chalmers RM, Robertson N, Compston DAS, et al. Sequence of mitochondrial DNA in patients with multiple sclerosis. Ann Neurol 1996;40:239-43.
19. Pfeffer G, Burke A, Yu-Wai-Man P, et al. Clinical features of MS associated with Leber hereditary optic neuropathy mtDNA mutations. Neurology 2013;81:2073-81.
20. Hirst C, Ingram G, Pickersgill T, et al. Increasing prevalence and incidence of multiple sclerosis in South East Wales. J Neurol Neurosurg Psychiatry 2009;80:386-91.